Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
92,315,749
-
Total 13F shares
-
96,694,108
-
Share change
-
+3,510,758
-
Total reported value
-
$6,530,007,628
-
Put/Call ratio
-
25%
-
Price per share
-
$67.54
-
Number of holders
-
303
-
Value change
-
+$227,828,935
-
Number of buys
-
142
-
Number of sells
-
184
Institutional Holders of Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) as of Q2 2024
As of 30 Jun 2024,
Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) was held by
303 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
96,694,108 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., T. Rowe Price Investment Management, Inc., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, VIKING GLOBAL INVESTORS LP, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, JPMORGAN CHASE & CO, and CITADEL ADVISORS LLC.
This page lists
304
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.